Examination of human tissue cytosols for expression of sulfotransferase isoform 1A2 (SULT1A2) using a SULT1A2-specific antibody

Molecular Pharmacology

Volumn 67, Issue 2, 2005, Pages 394-399

  Nowell, Susan ^a,b   Green, Bridgett ^a   Yong, Ming Tang ^c   Wiese, Rick ^d   Kadlubar, Fred F ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d Pierce Biotechnology Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ANTIBODY; SULFOTRANSFERASE; SULFOTRANSFERASE ISOFORM 1A2; SULFOTRANSFERASE ISOFORM 1A2 SPECIFIC ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CYTOSOLIC FRACTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANTIBODIES; ARYLSULFOTRANSFERASE; CYTOSOL; HUMANS; IMMUNE SERA; ISOENZYMES; LIVER; MOLECULAR SEQUENCE DATA; PROTEIN ARRAY ANALYSIS; RECOMBINANT PROTEINS;

EID: 13444261488     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.006171     Document Type: Article

References (14)

1. Arlt VM, Glatt H, Muckel E, Pabel U, Sorg BL, Seidel A, Frank H, Schmeiser HH, and Phillips DH (2003) Activation of 3-nitrobenzanthrone and its metabolites by human acetyltransferases, sulfotransferases and cytochrome P450 expressed in Chinese hamster V79 cells. Int J Cancer 105:583-592.
2. Bernatowicz MS and Matsueda GR (1986) Preparation of peptide-protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional crosslinking reagent. Anal Biochem 155:95-102.
3. Chou HC, Lang NP, and Kadlubar FF (1995) Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Res 55:525-529.
4. Dooley TP, Haldeman-Cahill R, Joiner J, and Wilborn TW (2000) Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells. Biochem Biophys Res Commun 277:236-245.
5. Falany CN, Xie X, Wang J, Ferrer J, and Falany JL (2000) Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain. Biochem J 346:857-864.
6. Glatt H and Meinl W (2004a) Pharmacogenetics of soluble sulfotransferases (SULTs). Naunyn Schmiedeberg's Arch Pharmacol 369:55-68.
7. Glatt H and Meinl W (2004b) Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of sulfotransferases and acetyltransferases in nitrofen mutagenicity. Carcinogenesis 25:779-786.
8. Hou MF, Chen ST, Chen JC, Yeh KT, Lee TP, Chen CM, Shih MC, Lin CC, and Chang JG (2002) Sulfotransferase 1A2*2 is a risk factor for early-onset breast cancer. Int J Mol Med 10:609-612.
9. Jakoby WB and Ziegler DM (1990) The enzymes of detoxication. J Biol Chem 265:20715-20718.
10. Meinl W, Meerman JH, and Glatt H (2002) Differential activation of promutagens by alloenzymes of human sulfotransferase 1A2 expressed in Salmonella typhimurium. Pharmacogenetics 12:677-689.
11. Minchin RF, Ilett KF, Teitel CH, Reeves PT, and Kadlubar FF (1992) Direct O-acetylation of N-hydroxy arylamines by acetylsalicylic acid to form carcinogen-DNA adducts. Carcinogenesis 13:663-667.
12. Peng CT, Chen JC, Yeh KT, Wang YF, Hou MF, Lee TP, Shih MC, Chang JY, and Chang JG (2003) The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese. Int J Mol Med 11:85-89.
13. Raftogianis RB, Wood TC, and Weinshilboum RM (1999) Human phenol sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties and human liver genotype-phenotype correlations. Biochem Pharmacol 58:605-616.
14. Tang YM, Chen GF, Thompson PA, Lin DX, Lang NP, and Kadlubar FF (1999) Development of an antipeptide antibody that binds to the C-terminal region of human CYP1B1. Drug Metab Dispos 27:274-280.